ArticleAmerican journal of cancer research2023

Effect of HER2-low-positive status on neoadjuvant chemotherapy and survival outcome of breast cancer: a 10-year dual-center retrospective study.

Yijun Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.